Related Experiment Videos
The US Food and Drug Administration's Model-Informed Drug Development Paired Meeting Pilot Program: Early Experience
Rajanikanth Madabushi1, Jessica M Benjamin1, Renmeet Grewal1
11Office of Clinical Pharmacology, Office of Translational Sciences, US Food and Drug Administration, Silver Spring, Maryland, USA.
Clinical Pharmacology and Therapeutics
|May 14, 2019
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Proteomic Identification of Plasma Biomarkers of Response to IL-5 Inhibitor Biologics in Healthy Subjects.
Clinical and translational science·2025
Cannabidiol and Liver Enzyme Level Elevations in Healthy Adults: A Randomized Clinical Trial.
JAMA internal medicine·2025
Characterization of Proteomic Pharmacodynamic Biomarkers of IFNβ-1a Biologics to Inform Potential Utility in Biosimilar Development.
Clinical pharmacology and therapeutics·2025
Development and validation of a high-throughput LC-MS/MS bioanalytical method for the simultaneous quantification of cannabidiol and metabolites in human plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2025
Effect of midazolam co-administered with oxycodone on ventilation: a randomised clinical trial in healthy volunteers.
British journal of anaesthesia·2025
Untargeted Metabolomics Reveal New Endogenous Plasma Biomarkers Associated with CYP3A Inhibition in Humans.
Clinical pharmacology and therapeutics·2026
A Practical Guide to Implementing Real-World Evidence as Primary Basis for Approval and Label Expansion.
Clinical pharmacology and therapeutics·2026
Model-based clinical pharmacology profiling of subcutaneous nivolumab in renal cell carcinoma: Bridging to alternative dosing regimens and indications.
Clinical pharmacology and therapeutics·2026
Trust, but Verify: Translating Dosing Evidence to Understudied Populations in Low- and Middle-Income Countries.
Clinical pharmacology and therapeutics·2026
From Biological Mechanisms to Causal Inference: Quantitative Systems Pharmacology and Causal Frameworks in Drug Development.
Clinical pharmacology and therapeutics·2026
PDBe PISA: Enhanced Analysis of Macromolecular Interactions.
Current protocols·2026
Formulation and Physicochemical Characterization of Paliperidone- Loaded Niosomal Vesicles for Improved Transdermal Drug Delivery.
Recent advances in drug delivery and formulation·2026
DesignMaster: A Multi-Conditional Diffusion Framework for Rational PROTAC Design.
Bioinformatics (Oxford, England)·2026
Understanding the influence of stabiliser selection and concentration on the physical stability of dual-drug co-suspensions.
International journal of pharmaceutics·2026